SCHEMBL3320490

SCHEMBL3320490

CCCC[C@H](CN(O)C=O)C(=O)N1CCN(c2ccccc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
TSHR P16473 3/20 0.48
NPSR1 Q6W5P4 3/20 0.46
MAPT P10636 1/20 0.46
CHEK1 O14757 1/20 0.46
PLA2G1B P04054 1/20 0.44
KMT2A Q03164 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 2/20 0.43
BMP1 P13497 1/20 0.43
RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3320488 1.00 LMNA (0.48) LMNATSHRNPSR1MAPTCHEK1
SCHEMBL3320090 0.89 CNR1 (0.51) LMNATSHRMAPTKMT2AALDH1A1
SCHEMBL3320351 0.89 CNR1 (0.50) LMNAMAPTKMT2AALDH1A1MAPK1
SCHEMBL3320349 0.89 CNR1 (0.50) LMNAMAPTKMT2AALDH1A1MAPK1
SCHEMBL3320089 0.89 CNR1 (0.51) LMNATSHRMAPTKMT2AALDH1A1
SCHEMBL3317757 0.89 TSHR (0.53) LMNATSHRNPSR1MAPTKMT2A
SCHEMBL3317761 0.89 TSHR (0.53) LMNATSHRNPSR1MAPTKMT2A
SCHEMBL3320190 0.88 MAPT (0.49) LMNAMAPTKMT2AALDH1A1MAPK1
SCHEMBL3320188 0.88 MAPT (0.49) LMNAMAPTKMT2AALDH1A1MAPK1
SCHEMBL3321294 0.87 L3MBTL1 (0.46) LMNAMAPTKMT2AALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100125075-A1 Antibacterial Agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2010-05-20 US disclosed
US-20100125075-A1 Antibacterial Agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2010-05-20 US disclosed
US-7186719-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS (GB) 2007-03-06 US disclosed
US-7186719-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS (GB) 2007-03-06 US disclosed
US-7186719-B2 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS (GB) 2007-03-06 US disclosed
US-20050065095-A1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) 2005-03-24 US disclosed
US-6846825-B1 Antibacterial agents BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2005-01-25 US disclosed
EP-1202968-A2 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2002-05-08 EP disclosed
WO-2001010834-A9 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARM (GB) 2001-08-09 WO disclosed
WO-2001010834-A2 ANTIBACTERIAL AGENTS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065095-A1 Antibacterial agents NQO2, DAO, Q6ZSR9 LMNA 2462/4885TSHR 947/4885NPSR1 1108/4885
US-20100125075-A1 Antibacterial Agents NQO2, DAO, Q6ZSR9 LMNA 2435/4885TSHR 873/4885NPSR1 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.